NASA X: Environmentally Responsible Aviation
2009/04/14 by Zhan‐Guo Gao, Zhanguo Gao, Jun Yin +7 · 43 citations
Physics and Astronomy · #Space exploration and regulation
paper · pdf · doi:10.2337/db08-1637
Abstract
Dietary supplementation of butyrate can prevent and treat diet-induced insulin resistance in mouse. The mechanism of butyrate action is related to promotion of energy expenditure and induction of mitochondria function.
Cited by
- Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice
- The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
- The gut microbiome: a core regulator of metabolism
- Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals
- Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
- Gut microbiota, obesity and diabetes
- Regulation of adipokine production in human adipose tissue by propionic acid
- A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease
- Short-term sleep restriction in humans alters diurnal circulating metabolite profiles, including those of microbial origin
- β-Hydroxybutyrate: A Signaling Metabolite
- Anatomy and physiology of the nutritional system
- Sodium acetate, propionate, and butyrate reduce fat accumulation in mice via modulating appetite and relevant genes
- The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies
- Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases
- The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
- Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications
- Association of gut microbiota with overweight/obesity combined with gestational diabetes mellitus
- Gut microbiota role in dietary protein metabolism and health-related outcomes: The two sides of the coin
- Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
- Microbial degradation of complex carbohydrates in the gut. [europepmc]
- Gut microbiota from twins discordant for obesity modulate metabolism in mice. [europepmc]
- Ketone bodies as signaling metabolites. [europepmc]
- Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. [europepmc]
- Gut dysbiosis is linked to hypertension. [europepmc]
- Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. [europepmc]
- Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. [europepmc]
- Gut Microbiota in Cardiovascular Health and Disease. [europepmc]
- β-Hydroxybutyrate: A Signaling Metabolite. [europepmc]
- Butyrate: A Double-Edged Sword for Health? [europepmc]
- Metabolites as regulators of insulin sensitivity and metabolism. [europepmc]
- Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. [europepmc]
- Dietary lipids, gut microbiota and lipid metabolism. [europepmc]
- Role of gut microbiota in type 2 diabetes pathophysiology. [europepmc]
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. [europepmc]
- The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? [europepmc]
- Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. [europepmc]
- The Gut Microbiota and Inflammation: An Overview. [europepmc]
- Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. [europepmc]
- Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases. [europepmc]
- The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. [europepmc]
- Dietary Fibre Modulates the Gut Microbiota. [europepmc]
- Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. [europepmc]
- Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. [europepmc]
- Short-chain fatty acids in diseases. [europepmc]
Related